Caffeine and the CYP1A2 gene

The same cup of coffee can be good for one person and risky for another. The difference is not the coffee, it is how long the caffeine stays in your system, and that is genetic.

One enzyme clears almost all your caffeine

Roughly 95% of the caffeine you drink is broken down by a single liver enzyme, made by the CYP1A2 gene. How quickly it works decides how long caffeine circulates and keeps acting on your heart and blood vessels.

Fast and slow metabolisers

The variant rs762551 splits people into two groups. Fast metabolisers (A/A) clear caffeine quickly. Slow metabolisers (C-carriers) hold on to it far longer, so each cup acts on the body for much more time.

Why it matters for your heart

In slow metabolisers, higher coffee intake is associated with raised blood pressure and increased cardiovascular risk, because the caffeine keeps acting. In fast metabolisers, moderate coffee is generally neutral and can even be protective. Same drink, opposite verdict.

What actually helps

Slow metabolisers benefit from capping caffeine, especially in the afternoon, and from watching hidden sources like tea, cola, energy drinks and dark chocolate. Fast metabolisers have more room, but the same “know your ceiling” logic applies. Your genotype turns a vague guideline into a personal number.

The science, in depth

rs762551 (-163C>A) is a regulatory polymorphism that modifies CYP1A2 activity and inducibility. Because slow clearance prolongs systemic caffeine exposure, epidemiological data show genotype-dependent associations between coffee intake and hypertension and myocardial-infarction risk, with the adverse signal concentrated in C-carriers at higher intakes.